Skip to main content
Premium Trial:

Request an Annual Quote

NIEHS Awards Caliper Knockout Mouse Model Contract Worth Up To $7M

NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has received a contract from the National Institutes of Environmental Health Services valued at up to $7 million to develop customized transgenic and knockout mouse models though its Xenogen Biosciences business.
The company said the contract will begin immediately and could run up to 10 years “at the option of NIEHS.” The contract was awarded to Caliper through a competitive bid process.
Caliper said the NIEHS will use the genetically modified mouse models as part of its research to identify and possibly prevent hazardous conditions and exposure in humans.
Caliper said it has made over 9,000 unique mouse and rat models, some of which have already been supplied to the NIEHS through a previous multi-year agreement.
Xenogen is the in vivo pharmaceutical drug-discovery branch of Caliper Discovery Alliances & Services.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.